85 related articles for article (PubMed ID: 10951575)
21. Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors.
Mikkers H; Nawijn M; Allen J; Brouwers C; Verhoeven E; Jonkers J; Berns A
Mol Cell Biol; 2004 Jul; 24(13):6104-15. PubMed ID: 15199164
[TBL] [Abstract][Full Text] [Related]
22. Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway.
Mochizuki T; Kitanaka C; Noguchi K; Muramatsu T; Asai A; Kuchino Y
J Biol Chem; 1999 Jun; 274(26):18659-66. PubMed ID: 10373478
[TBL] [Abstract][Full Text] [Related]
23. Pim-1 kinase and p100 cooperate to enhance c-Myb activity.
Leverson JD; Koskinen PJ; Orrico FC; Rainio EM; Jalkanen KJ; Dash AB; Eisenman RN; Ness SA
Mol Cell; 1998 Oct; 2(4):417-25. PubMed ID: 9809063
[TBL] [Abstract][Full Text] [Related]
24. The PIM family of oncoproteins: small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets.
Saurabh K; Scherzer MT; Shah PP; Mims AS; Lockwood WW; Kraft AS; Beverly LJ
Oncotarget; 2014 Sep; 5(18):8503-14. PubMed ID: 25238262
[TBL] [Abstract][Full Text] [Related]
25. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.
van Lohuizen M; Verbeek S; Krimpenfort P; Domen J; Saris C; Radaszkiewicz T; Berns A
Cell; 1989 Feb; 56(4):673-82. PubMed ID: 2537153
[TBL] [Abstract][Full Text] [Related]
26. Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival.
Hammerman PS; Fox CJ; Birnbaum MJ; Thompson CB
Blood; 2005 Jun; 105(11):4477-83. PubMed ID: 15705789
[TBL] [Abstract][Full Text] [Related]
27. Structure and substrate specificity of the Pim-1 kinase.
Bullock AN; Debreczeni J; Amos AL; Knapp S; Turk BE
J Biol Chem; 2005 Dec; 280(50):41675-82. PubMed ID: 16227208
[TBL] [Abstract][Full Text] [Related]
28. [Expression of Pim-2 in normal liver and hepatocellular carcinoma tissues].
Li B; Ye T; Li DH
Zhonghua Gan Zang Bing Za Zhi; 2008 Dec; 16(12):950-1. PubMed ID: 19105947
[No Abstract] [Full Text] [Related]
29. The Pim-1 kinase stimulates maturation of TCRbeta-deficient T cell progenitors: implications for the mechanism of Pim-1 action.
Leduc I; Karsunky H; Mathieu N; Schmidt T; Verthuy C; Ferrier P; Möröy T
Int Immunol; 2000 Oct; 12(10):1389-96. PubMed ID: 11007756
[TBL] [Abstract][Full Text] [Related]
30. Pim-1 translocates sorting nexin 6/TRAF4-associated factor 2 from cytoplasm to nucleus.
Ishibashi Y; Maita H; Yano M; Koike N; Tamai K; Ariga H; Iguchi-Ariga SM
FEBS Lett; 2001 Sep; 506(1):33-8. PubMed ID: 11591366
[TBL] [Abstract][Full Text] [Related]
31. Pim-1 activation of cell motility induces the malignant phenotype of tongue carcinoma.
Tanaka S; Kitamura T; Higashino F; Hida K; Ohiro Y; Ono M; Kobayashi M; Totsuka Y; Shindoh M
Mol Med Rep; 2009; 2(2):313-8. PubMed ID: 21475831
[TBL] [Abstract][Full Text] [Related]
32. Involvement of PIM-1 in DNA fragmentation in mouse NS-1-derived cells.
Takahashi C; Harada Y; Ariga H; Iguchi-Ariga SM
Biochem Biophys Res Commun; 1995 Oct; 215(2):538-46. PubMed ID: 7487989
[TBL] [Abstract][Full Text] [Related]
33. Ectopic over-expression of oncogene Pim-2 induce malignant transformation of nontumorous human liver cell line L02.
Ren K; Duan W; Shi Y; Li B; Liu Z; Gong J
J Korean Med Sci; 2010 Jul; 25(7):1017-23. PubMed ID: 20592892
[TBL] [Abstract][Full Text] [Related]
34. In vivo analysis of Pim-1 deficiency.
Laird PW; van der Lugt NM; Clarke A; Domen J; Linders K; McWhir J; Berns A; Hooper M
Nucleic Acids Res; 1993 Oct; 21(20):4750-5. PubMed ID: 8233823
[TBL] [Abstract][Full Text] [Related]
35. Buettner R, Morales C, Caserta E, et al. Leflunomide regulates c-Myc expression in myeloma cells through PIM targeting. Blood Adv. 2019;3(7):1027-1032.
Blood Adv; 2022 Nov; 6(21):5797. PubMed ID: 36349910
[No Abstract] [Full Text] [Related]
36. Re: Endogenous Formaldehyde is a Hematopoietic Stem Cell Genotoxin and Metabolic Carcinogen.
Atala A
J Urol; 2016 Jul; 196(1):279-80. PubMed ID: 27321538
[No Abstract] [Full Text] [Related]
37. PIM1 Promotes Survival of Cardiomyocytes by Upregulating c-Kit Protein Expression.
Ebeid DE; Firouzi F; Esquer CY; Navarrete JM; Wang BJ; Gude NA; Sussman MA
Cells; 2020 Aug; 9(9):. PubMed ID: 32878131
[TBL] [Abstract][Full Text] [Related]
38. PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.
Luszczak S; Kumar C; Sathyadevan VK; Simpson BS; Gately KA; Whitaker HC; Heavey S
Signal Transduct Target Ther; 2020 Jan; 5(1):7. PubMed ID: 32296034
[TBL] [Abstract][Full Text] [Related]
39. The regulatory role of protein phosphorylation in human gammaherpesvirus associated cancers.
Wang Y; Banerjee S; Ding L; Cai C; Wei F; Cai Q
Virol Sin; 2017 Oct; 32(5):357-368. PubMed ID: 29116588
[TBL] [Abstract][Full Text] [Related]
40. IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21.
Lui AJ; Geanes ES; Ogony J; Behbod F; Marquess J; Valdez K; Jewell W; Tawfik O; Lewis-Wambi J
Cancer Lett; 2017 Jul; 399():29-43. PubMed ID: 28411130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
